Research graph
References from Low‐Dose Cytarabine Plus G‐ CSF Induction in Pediatric M2 Acute Myeloid Leukemia: A Multicenter Study. Local targets link to admitted publications; unresolved targets remain external evidence.
Pediatric Acute Myeloid Leukemia‐Past, Present, and Future
10.3390/jcm11030504 · 2022 · External reference
How I Treat Pediatric Acute Myeloid Leukemia
10.1182/blood.2021011694 · 2021 · External reference
Children's Oncology Group's 2023 Blueprint for Research: Myeloid Neoplasms
10.1002/pbc.30584 · 2023 · External reference
Risk‐Stratified Therapy for Pediatric Acute Myeloid Leukemia
10.3390/cancers15164171 · 2023 · External reference
Ecological Principle Meets Cancer Treatment: Treating Children With Acute Myeloid Leukemia With Low‐Dose Chemotherapy
10.1093/nsr/nwz006 · 2019 · External reference
Minimally Myelosuppressive Regimen for Remission Induction in Pediatric AML: Long‐Term Results of an Observational Study
10.1182/bloodadvances.2020003453 · 2021 · External reference
A Low‐ Versus Standard‐Dose Regimen as Induction for Pediatric AML: A Multicenter, Randomized Noninferiority Trial
10.1182/blood.2025030972 · 2026 · External reference
Distinct Genomic Landscape of Chinese Pediatric Acute Myeloid Leukemia Impacts Clinical Risk Classification
10.1038/s41467-022-29336-y · 2022 · External reference
Acute Myeloblastic Leukemia (ANLL‐M2) With t(8;21)(q22;q22) Variant Expressing Lymphoid but Not Myeloid Surface Antigens With a High Number of G‐CSF Receptors
10.1016/0145-2126(93)90026-h · 1993 · External reference
Effect of Priming With Granulocyte Colony‐Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia
10.1056/nejmoa025406 · 2003 · External reference
Treatment With G‐CSF Reduces Acute Myeloid Leukemia Blast Viability in the Presence of Bone Marrow Stroma
10.1186/s12935-015-0272-3 · 2015 · External reference
Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony‐Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML‐BFM 98
10.1200/jco.2006.06.5037 · 2006 · External reference
Prophylactic Human Granulocyte Colony‐Stimulating Factor After Induction Therapy in Pediatric Acute Myeloid Leukemia
10.1182/blood-2006-07-035915 · 2007 · External reference
Infectious Complications in Children With Acute Myeloid Leukemia: Decreased Mortality in Multicenter Trial AML‐BFM 2004
10.1038/bcj.2015.110 · 2016 · External reference
Clinical Profiling of AML1:ETO and KIT Exon 17 Mutation in Pediatric AML by High‐Throughput Drug Sensitivity
2026 · External reference
Risk‐Directed Therapy Based on Genetics and MRD Improves the Outcomes of AML1‐ETO‐Positive AML Patients, a Multi‐Center Prospective Cohort Study
10.1038/s41408-023-00941-4 · 2023 · External reference
Overexpression of TREM1 Predicts Poor Prognosis and Chemotherapy Resistance in Egyptian Acute Myeloid Leukemia Associated With FLT3 Internal Tandem Duplication and CD123 Expression and Stemness Signatures
10.1007/s12672-026-05009-w · 2026 · External reference
